Status:
UNKNOWN
Metabolic and Infectious Diseases in La Réunion (the REUNION Population-based Study)
Lead Sponsor:
Institut National de la Santé Et de la Recherche Médicale, France
Conditions:
Infectious Disease
Cardiovascular Diseases
Eligibility:
All Genders
18-67 years
Brief Summary
The aim of the present study is to determine the prevalence of cardiometabolic and infectious disease in La Reunion (french oversea department and region of France). Known or suspected risk factor fo...
Detailed Description
Overall, 2000 men and women will be recruited during two years for an extensive clinical examination including a microbiota, blood, hair and DNA collection, cognitive tests, autonomous nervous system ...
Eligibility Criteria
Inclusion
- 18-67 years
- given consent for genetic analysis,
- written consent for participating in the study
Exclusion
- judicial protection or guardianship
Key Trial Info
Start Date :
May 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2024
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT05400824
Start Date
May 1 2022
End Date
May 1 2024
Last Update
July 5 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier Universitaire de La Réunion
La Réunion, Saint-Pierre, France, 97448